Lifeboat Foundation

Scientists at Harvard have created a texture in meat grown in a lab close to the actual animal meat we’re used to. Would you eat it?
» Subscribe to Seeker!http://bit.ly/subscribeseeker
» Watch more Elements! http://bit.ly/ElementsPlaylist

Human meat consumption is bad for the planet—livestock raised for food makes up for approximately 14–18% of our greenhouse gas emissions, and the land requirements to grow their food is responsible for nearly 80% of all deforestation in the Amazon.

Continue reading “This Breakthrough in Lab-Grown Meat Could Make it Look Like Real Flesh” »

Researchers are designing a stingray-shaped spacecraft to explore the dark side of Venus.

(Image: © CRASH Lab, University at Buffalo)

Could a stingray-shaped spacecraft get to the dark side of Venus by flapping its wings?

Continue reading “This Stingray-Shaped Spacecraft Could Be Perfect For Exploring Venus’ Dark Side” »

Innovative nanosheets made from equal parts of hydrogen and boron have a greater capacity to store and release hydrogen compared with conventional metal-based materials.

Circa 2018

Researchers at MIT (Cambridge, MA) and at Brookhaven National Laboratory (Upton, NY) have demonstrated a new approach to controlling magnetism in a microchip that could lead to next-generation memory and logic devices that consume drastically less power than current versions.

Join our global movement to extend the human healthspan by accelerating research, innovation, and entrepreneurism in healthy longevity.

face_with_colon_three

There’s no telling what you can do when you put your mind to it. Take Richard Hull, he built a small-scale fusion reactor—in a shed, in his backyard. A retired electronics engineer, Hull took a special interest in nuclear fusion. He lives in Lakeside, Virginia, with his cats and likes to pass on his knowledge and collaborate with others on projects. So he invites amateur scientists from all over the United States to meet at his home once a year to check out his reactor and share their inventions.

Continue reading “This Amateur Physicist Built a Fusion Reactor in His Backyard” »

While many futures are generalists, there is a need for foresight professionals centered on specific fields, as well. Perhaps no area is more in need of innovative outlooks for the future than healthcare. With rising costs, aging populations and personnel shortages, the challenges are many. But so are the opportunities to employ emerging technologies. In the first part of a two part series, host Mark Sackler discusses these challenge with two nursing Ph.D.’s, Oriana Beaudet and Dan Pesut. Part One addresses the need for foresight both in nursing specifically and healthcare in general, as well as the global challenges of an aging population. Part two will drill down to individual ssues, including automation, robotics and artificial intelligence as caregiving tools for the future.

The televised gala, broadcast on the National Geographic Channel as well as YouTube and China’s Tencent, whose founder Ma Huateng is also a sponsor, played heavily on a theme that’s become somewhat tarnished in Silicon Valley in recent years—that scientific and technological progress will solve humanity’s biggest problems. For the past two years, Facebook and Google have both been battered by lawmakers and the public for how they’ve failed to eliminate the spread of fake news, conspiracy theories (sometimes about science) and content that connects violent extremists. Both Zuckerberg and Pichai have also countered rising complaints from the tech giants’ workforces.

Some of the top scientists who accepted Breakthrough Prize awards used the nationally broadcast ceremony to decry the spread of misinformation, problems that continue to dog the tech giants whose leaders, including Facebook CEO Mark Zuckerberg and Google CEO Sundar Pichai, celebrated at the glitzy Silicon Valley gala Sunday evening.

“Science is a rock of truth in a sea of fake news,” said physicist Peter van Nieuwenhuizen, who with collaborators Sergio Ferrara and Daniel Freedman accepted an award Sunday evening for their work around the theory of supergravity.

Continue reading “At Gala Held” »

Holon-based cancer immunotherapy company Compugen disclosed encouraging preliminary results on Tuesday from its Phase 1 clinical trial for an antibody acting against a novel cancer drug target (PVRIG) in patients with advanced solid tumors.

The Nasdaq and Tel Aviv-listed company, a pioneer in predictive drug target discovery, has developed innovative computational discovery platforms to identify new drug targets and subsequently produce first-in-class therapeutics. The clinical trial of the anti-PVRIG antibody, called COM701, aimed to assess the safety of escalating doses of the therapy in patients with advanced solid tumors, but also demonstrated initial signals of anti-tumor activity in the heavily pre-treated patient population enrolled in the study.

“We are encouraged by the emerging safety profile and initial signals of anti-tumor activity of COM701,” said Compugen president and CEO Dr. Anat Cohen-Dayan.